FEROZ 1QFY27 profit jumps 23%

Mettis Global reported that Ferozsons Laboratories’ consolidated profit after tax rose 22.9% to Rs395.77 million in the quarter ended September 30, 2026, from Rs321.95 million a year earlier. Earnings per share increased 24.4% to Rs7.40, while net revenue advanced 19.1% to Rs7.07 billion.

Gross profit grew 24.3% to Rs3.24 billion, and the gross margin widened to 45.85% from 43.94%. Selling and distribution expenses climbed 26.6% to Rs2.12 billion, while other income nearly halved to Rs26.07 million; operating profit nevertheless rose 16.3% to Rs748.05 million. Finance costs increased 5.7% to Rs110.64 million, and income tax expense was up 9.7% at Rs229.06 million. The results cover Ferozsons’ first quarter of FY27.